FDA says FLAVNT Streetwear sold breast binders as medical devices without registering or listing them for fiscal 2026.
What happened
FDA reviewed FLAVNT's website and found breast binders for sale with statements that they help with gender dysphoria and compress breast tissue, which FDA says makes them devices. FDA also cited a website statement that the firm manufactures the devices and said records show no registration or listing for fiscal year 2026. FDA called the devices misbranded.
What FDA found
The firm did not annually register its device establishment with FDA.
section 510 of the Act, 21 U.S.C. § 360The firm did not submit device listing information for the breast binders.
section 510(j) of the Act, 21 U.S.C. § 360(j)Because the devices were made in an unregistered establishment and were not listed, FDA calls them misbranded.
section 502(o) of the Act, 21 U.S.C. § 352(o)
What FDA wants
FDA tells FLAVNT to notify the office in writing within 15 business days of steps taken to correct the violations and prevent recurrence, with documentation and a timetable if actions will take longer. If the firm believes the products are not violating the law, it should include its reasoning and supporting information.
Who should pay attention
- online sellers of health-related apparel
- small medical device firms
- brands making therapeutic or body-affecting claims on their websites
This is a summary. Read the original letter on fda.gov.